<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="https://catalogues.royalsociety.org:443/CalmView/record/catalog/HF/1/19/4/59/54" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Letter from Howard Walter Florey to Lord Halsbury, National Research Development Corporation, Tilney Street, London</dc:title>
  <dc:description>Says Wilkins told him that Glaxo were to try to determine best method of brewing Cephalosporin C - told Wilkins this aspect of the work was being handled at Clevedon - Wilkins did not mention proposal to give Glaxo exclusive licence for 18 months - only Abraham and Newton appear on cephalosporin C patents - main interest at Oxford is to get enough cephalosporin C for chemical work - worried that Glaxo might try to determine structure of cephalosporin C - comments on this - would like Abarham's advice about question of exclusive licence, as Abraham knows what ICI is doing - comments on this - asks if NRDC could wait until mid-September so that they can have Abraham's views.</dc:description>
  <dc:date>10 August 1957</dc:date>
</rdf:Description>